Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors

NCT01525602 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: PLX3397
DRUG: Paclitaxel

Sponsor

Daiichi Sankyo

Collaborators

[object Object]